Sign in with Google. Opens in new tab
ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

331
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
bearishXtalPi Holdings
29 May 2024 22:00

QuantumPharm (Xtalpi) Pre-IPO - PHIP Updates - Strong Growth, Although Losses Continue to Pile Up

QuantumPharm (QUP HK) (Xtalpi) is looking to raise US$200m in its upcoming Hong Kong IPO. In this note, we discuss QuantumPharm's PHIP updates.

Logo
581 Views
Share
23 May 2024 00:22

Taiwan Shines as China & Japan Decline:  Global Funds Top-Down Positioning Report

Taiwan allocations rise in face of subdued Asia.  USA dominant though Value funds increase underweights.  UK, France & Netherlands remain key...

Logo
359 Views
Share
bullishIndegene
10 May 2024 03:28

Indegene IPO Trading - High Anchor Quality + Strong Demand, Expect a Pop on Debut

Indegene Limited (1864095D IN) raised around US$220m in its India IPO, via selling a mix of primary and secondary shares. In this note, we will...

Logo
555 Views
Share
bearishWuXi XDC Cayman
07 May 2024 23:00

Wuxi XDC Lock-Up - US$300m Lockup Expiry Could See Some Selling Owing to the Regulatory Overhang

WuXi XDC Cayman (2268 HK) was listed in Hong Kong on 17th Nov 2023 after raising US$470m. Its six-month lockup will expire on 16th May 2024.

Logo
573 Views
Share
bullishIndegene
03 May 2024 02:29

Indegene IPO - Marquee Clients, Strong Track Record, Decent Valuation

Indegene Limited (1864095D IN) is looking to raise US$220m in its India IPO, via selling a mix of primary and secondary shares.

Logo
540 Views
Share
x